Skip to main content

Sequenom Will Receive Nasdaq Delisting Warning if Shares Close Below $1 Today

NEW YORK, Sept. 15 (GenomeWeb News) - Sequenom will receive a delisting warning letter from the Nasdaq exchange if the company's share price closes below $1 today.


Sequenom's shares have been trading below $1 for the last 29 days, closing at $.89 yesterday. Nasdaq sends out delisting warning letters whenever a company's stock fails to keep the closing price of its shares at or above $1 for 30 consecutive trading days.


This is not the first time that Sequenom comes close to a Nasdaq warning. In December, the company missed a warning letter by a single day, and came similarly close in September of 2004.


Yesterday, the company said it will will lay off around 30 percent of its workforce, or 44 staffers, in a large-scale restructuring aimed at cutting costs and redirecting resources.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.